Literature DB >> 3661528

Coffee consumption and mortality in the Chicago Western Electric Company Study.

D LeGrady1, A R Dyer, R B Shekelle, J Stamler, K Liu, O Paul, M Lepper, A M Shryock.   

Abstract

The relations between coffee consumption and 19-year mortality from all causes, coronary heart disease, and non-coronary causes were assessed in 1,910 white males aged 40-56 years in 1957-1958 from the Chicago Western Electric Company Study. Mortality rates, adjusted for age, serum cholesterol, diastolic blood pressure, and smoking status, were compared for those consuming 0-1, 2-3, 4-5, and 6+ cups of coffee per day; coffee intake, measured at the first anniversary examination, included both caffeinated and decaffeinated intake. Mortality from all causes was greatest in the highest and lowest intake groups. The increased mortality in the 6+ cups per day group was due to coronary heart disease, while the increased mortality in the lowest intake group was due to noncoronary causes. The adjusted relative risk of coronary heart disease death for those drinking 6+ cups of coffee per day compared with those drinking less was 1.71 (95 per cent confidence limits 1.27, 2.30). This increased risk of coronary heart disease death was present in both smokers and nonsmokers, with adjusted relative risks of 1.62 and 2.21, respectively (95 per cent confidence limits 1.17, 2.24 and 1.06, 4.62). The increased mortality from non-coronary causes in the lowest intake group was due primarily to increased mortality from cancer and cardiovascular diseases other than coronary heart disease. The results of this study support the hypothesis that those who drink 6+ cups of coffee per day may be at an increased risk of death from coronary heart disease.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3661528     DOI: 10.1093/oxfordjournals.aje.a114717

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  23 in total

1.  Caffeine under examination--a passing grade.

Authors:  M G Myers
Journal:  West J Med       Date:  1992-11

2.  Effects of caffeine with repeated dosing.

Authors:  C P Denaro; C R Brown; P Jacob; N L Benowitz
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

3.  Association of coffee drinking with total and cause-specific mortality.

Authors:  Neal D Freedman; Yikyung Park; Christian C Abnet; Albert R Hollenbeck; Rashmi Sinha
Journal:  N Engl J Med       Date:  2012-05-17       Impact factor: 91.245

Review 4.  Dietary factors in rheumatic autoimmune diseases: a recipe for therapy?

Authors:  Shani Dahan; Yahel Segal; Yehuda Shoenfeld
Journal:  Nat Rev Rheumatol       Date:  2017-04-13       Impact factor: 20.543

5.  Association of coffee consumption with all-cause and cardiovascular disease mortality.

Authors:  Junxiu Liu; Xuemei Sui; Carl J Lavie; James R Hebert; Conrad P Earnest; Jiajia Zhang; Steven N Blair
Journal:  Mayo Clin Proc       Date:  2013-08-15       Impact factor: 7.616

6.  Coffee, lipids and atherosclerosis.

Authors:  R A Hegele
Journal:  CMAJ       Date:  1991-01-15       Impact factor: 8.262

7.  Coffee consumption and death from coronary heart disease in middle aged Norwegian men and women.

Authors:  A Tverdal; I Stensvold; K Solvoll; O P Foss; P Lund-Larsen; K Bjartveit
Journal:  BMJ       Date:  1990-03-03

8.  Coffee consumption and risk of all-cause, cardiovascular, and cancer mortality in smokers and non-smokers: a dose-response meta-analysis.

Authors:  Giuseppe Grosso; Agnieszka Micek; Justyna Godos; Salvatore Sciacca; Andrzej Pajak; Miguel A Martínez-González; Edward L Giovannucci; Fabio Galvano
Journal:  Eur J Epidemiol       Date:  2016-10-03       Impact factor: 8.082

9.  Coffee consumption and all-cause and cause-specific mortality: a meta-analysis by potential modifiers.

Authors:  Youngyo Kim; Youjin Je; Edward Giovannucci
Journal:  Eur J Epidemiol       Date:  2019-05-04       Impact factor: 8.082

10.  Association of Coffee Consumption With Total and Cause-Specific Mortality in 3 Large Prospective Cohorts.

Authors:  Ming Ding; Ambika Satija; Shilpa N Bhupathiraju; Yang Hu; Qi Sun; Jiali Han; Esther Lopez-Garcia; Walter Willett; Rob M van Dam; Frank B Hu
Journal:  Circulation       Date:  2015-11-16       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.